From January 1, 2022 to March 31, 2022, the company has repurchased 1,940,000 shares, representing 2.29% for $125 million. With this, the company has completed the repurchase of 1,940,000 shares, representing 2.29% for $125 million under the buyback announced on December 10, 2020.
Integra LifeSciences Holdings Corporation
Equities
IART
US4579852082
Medical Equipment, Supplies & Distribution
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
29.23 USD | -0.03% | -0.65% | -32.97% |
04-04 | North American Morning Briefing : Focus Turns to -2- | DJ |
04-03 | Citigroup Upgrades Integra LifeSciences to Neutral From Sell With $38 Price Target | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.97% | 2.3B | |
-3.45% | 186B | |
-2.62% | 107B | |
-3.88% | 67.44B | |
+3.24% | 50.03B | |
+16.06% | 47.81B | |
+4.79% | 41.03B | |
+1.57% | 26.85B | |
+2.81% | 25.82B | |
-0.36% | 25.01B |
- Stock Market
- Equities
- IART Stock
- News Integra LifeSciences Holdings Corporation
- Tranche Update on Integra LifeSciences Holdings Corporation's Equity Buyback Plan announced on December 10, 2020.